KINS
PrivateLast Round
Series C
Apr 1, 2025
Total Funding Raised
$11.1M
Company Overview
Kin Insurance is an insurtech company that provides a direct-to-consumer digital platform for homeowners, mobile home, condo, and landlord insurance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Subscription Commerce, Fashion & Beauty, Precision Medicine
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KINS Comparables
Compare KINS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 株式会社サイキンソー | 78% | |
| Viome Life Sciences, Inc. | 73% | |
| Calbee, Inc. | 69% | |
KINS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 1, 2025 | ||||
| VC Round | Jul 2, 2024 | ||||
| VC Round | Oct 4, 2023 | ||||
| Series B | Feb 22, 2022 | ||||
| Series A | Oct 29, 2020 |
Key People
Founding team and executive leadership
KINS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abies Ventures | Series B |
| JAFCO Group Co., Ltd. | Series B, Series A |
| Mizuho Capital | VC Round |
| 株式会社日本政策金融公庫 | VC Round |
| Astarte Capital Partners | Series B |
| Rakuten Capital | VC Round |
| Shizuoka Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
TAUNS Laboratories, Inc. participated in the Series C round.
- Feb 28, 2024
Grew 40% QoQ, from 10 to 14 employees.
KINS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KINS's valuation, stock price, and market status.